Clinical Trials Browser

Phase 2/3 × Leukemia, Hairy Cell × Clear all

NCT02131753 2024-08-22

Therapy Optimisation for the Treatment of Hairy Cell Leukemia

Phase 2/3 Recruiting

Other hematologic neoplasm

Leukemia, Hairy Cell